tiprankstipranks
Trending News
More News >
KOWA CO. LTD. (JP:7807)
:7807
Japanese Market

KOWA CO. LTD. (7807) AI Stock Analysis

Compare
0 Followers

Top Page

JP:7807

KOWA CO. LTD.

(7807)

Select Model
Select Model
Select Model
Outperform 80 (OpenAI - 4o)
Rating:80Outperform
Price Target:
¥914.00
▲(9.07% Upside)
KOWA CO. LTD. achieves a strong overall stock score driven primarily by its solid financial performance and attractive valuation. The technical analysis supports a stable outlook, although minor concerns about asset growth and revenue dip slightly temper the score.
Positive Factors
Strong Financial Performance
The company's ability to maintain profitability and manage debt effectively indicates a solid financial foundation, supporting long-term stability and growth potential.
Cash Flow Generation
Strong cash flow generation enhances financial flexibility, enabling the company to invest in growth opportunities and weather economic fluctuations.
Profit Margin Improvement
Improving profit margins reflect efficient cost management and operational strength, which are crucial for sustaining long-term profitability.
Negative Factors
Revenue Dip
A decline in revenue can indicate challenges in market demand or competitive pressures, potentially impacting future growth prospects if not addressed.
Asset Growth Concerns
Decreasing assets may suggest inefficiencies or underutilization, which could limit the company's ability to capitalize on growth opportunities.
EPS Decline
A significant decline in EPS growth can signal underlying operational challenges, impacting investor confidence and future earnings potential.

KOWA CO. LTD. (7807) vs. iShares MSCI Japan ETF (EWJ)

KOWA CO. LTD. Business Overview & Revenue Model

Company DescriptionKOWA CO. LTD. (7807) is a diversified Japanese company primarily engaged in the manufacturing and distribution of a wide range of products across various sectors, including pharmaceuticals, healthcare, and consumer goods. Established in 1894, KOWA has built a reputation for innovation and quality, offering products that enhance the well-being of individuals and communities. The company's core offerings include prescription medications, over-the-counter health products, and a selection of consumer goods, all underscored by a commitment to research and development.
How the Company Makes MoneyKOWA CO. LTD. generates revenue through multiple streams, with a significant portion coming from its pharmaceutical division, which includes both prescription drugs and over-the-counter products. The company invests heavily in research and development to bring new medications to market, thereby establishing a robust product pipeline that drives sales. Additionally, KOWA has formed strategic partnerships and collaborations with other pharmaceutical companies for co-development and distribution, which enhances its market reach and revenue potential. The company's consumer goods segment also contributes to its earnings, focusing on personal care and health-related products that cater to a broad consumer base. Overall, KOWA's diversified portfolio and strategic initiatives position it well for sustained financial growth.

KOWA CO. LTD. Financial Statement Overview

Summary
KOWA CO. LTD. demonstrates strong financial performance with consistent profitability, effective debt management, and robust cash flow generation. Despite minor concerns about asset growth and a revenue dip in 2025, the company's financial health is commendable.
Income Statement
85
Very Positive
KOWA CO. LTD. has demonstrated strong profitability with a consistent increase in gross and net profit margins over the past few years. The gross profit margin has remained robust, and the net profit margin improved significantly from a loss in 2020 to a healthy positive in 2025. Revenue growth has been stable, although there was a slight dip in 2025 compared to 2024. The EBIT and EBITDA margins have also shown positive trends, indicating efficient cost management and operational strength.
Balance Sheet
78
Positive
The company's balance sheet reflects strong equity growth with a solid equity ratio. The debt-to-equity ratio has improved over the years, suggesting effective debt management, and the return on equity has been positive. However, the total assets have slightly decreased, indicating potential concerns about asset growth or efficiency in asset utilization. Overall, the balance sheet shows a stable financial position with opportunities for better asset management.
Cash Flow
80
Positive
KOWA CO. LTD. has shown positive free cash flow growth, driven by strong operating cash flow. The free cash flow to net income ratio indicates good conversion of earnings into cash, supporting financial flexibility. Despite fluctuations in investing cash flow, the company has maintained healthy cash flow operations, evidencing prudent financial management. The operating cash flow to net income ratio is favorable, suggesting efficient cash generation from operations.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue6.41B6.37B6.40B6.27B5.72B5.25B
Gross Profit2.81B2.82B2.95B2.66B2.68B2.67B
EBITDA1.10B1.17B1.21B917.14M852.50M677.56M
Net Income506.80M616.20M710.43M438.31M400.96M389.40M
Balance Sheet
Total Assets4.90B4.89B4.82B5.16B5.03B5.08B
Cash, Cash Equivalents and Short-Term Investments1.65B1.69B1.02B1.24B1.38B1.83B
Total Debt616.81M393.50M940.09M1.23B1.53B2.77B
Total Liabilities1.88B1.88B2.34B2.68B2.78B3.86B
Stockholders Equity2.94B2.92B2.41B2.43B2.20B1.19B
Cash Flow
Free Cash Flow0.00642.99M690.14M502.38M352.85M553.76M
Operating Cash Flow0.00960.49M742.06M557.81M516.65M628.92M
Investing Cash Flow0.0038.48M92.96M-145.75M-215.42M-29.45M
Financing Cash Flow0.00-549.82M-1.09B-562.70M-822.92M-1.41B

KOWA CO. LTD. Technical Analysis

Technical Analysis Sentiment
Positive
Last Price838.00
Price Trends
50DMA
821.18
Positive
100DMA
817.34
Positive
200DMA
804.85
Positive
Market Momentum
MACD
3.15
Negative
RSI
59.56
Neutral
STOCH
83.37
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7807, the sentiment is Positive. The current price of 838 is above the 20-day moving average (MA) of 813.30, above the 50-day MA of 821.18, and above the 200-day MA of 804.85, indicating a bullish trend. The MACD of 3.15 indicates Negative momentum. The RSI at 59.56 is Neutral, neither overbought nor oversold. The STOCH value of 83.37 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:7807.

KOWA CO. LTD. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
80
Outperform
¥4.21B7.971.43%0.65%-39.91%
80
Outperform
¥8.06B5.461.80%8.56%2690.35%
70
Outperform
¥1.52B4.744.49%-9.48%-66.01%
66
Neutral
¥8.26B3.452.71%1.11%
61
Neutral
$18.38B12.79-2.54%3.03%1.52%-15.83%
51
Neutral
¥6.03B-10.79-23.54%-14.54%
46
Neutral
¥10.03B31.754.41%2.78%-88.37%
* Consumer Cyclical Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:7807
KOWA CO. LTD.
835.00
-75.09
-8.25%
JP:6612
BALMUDA, Inc.
705.00
-181.00
-20.43%
JP:7822
Eidai Co., Ltd.
226.00
27.82
14.04%
JP:7887
Nankai Plywood Co., Ltd.
9,250.00
4,149.46
81.35%
JP:7898
Wood One Co., Ltd.
884.00
54.43
6.56%
JP:7997
Kurogane Kosakusho Ltd.
888.00
187.37
26.74%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 29, 2025